Patent

Federal Circuit Overturns Major Patent Rulings in Apple-Optis Dispute, Calls for New Trial on Infringement and Damages

by

Tyler, Texas — In a significant ruling, the U.S. Court of Appeals for the Federal Circuit has analyzed the procedures surrounding jury verdict forms and evidentiary rules in a legal dispute over standard-essential patents (SEPs) between Optis Cellular Technology and Apple Inc. The case highlights complex issues surrounding jury unanimity, the validity of SEP claims, and the admission of evidence related to fair, reasonable, and non-discriminatory (FRAND) settlement terms. Optis brought a lawsuit against Apple in the Eastern District of Texas, claiming infringement of five patents essential to Long-Term Evolution (LTE) technology. The company alleged … Read more

Federal Circuit Overturns $300 Million Ruling in Optis vs. Apple, Cites Jury Errors in Landmark Patent Case

by

Alexandria, Virginia — In a pivotal ruling, the U.S. Court of Appeals for the Federal Circuit has overturned a $300 million judgment against Apple Inc. in the patent infringement case involving Optis Cellular Technology. The court identified multiple legal errors in the actions of the Eastern District of Texas that ultimately invalidated the jury’s decision. The Federal Circuit’s opinion, led by Judge Prost, pinpointed four significant areas of reversible error. The court highlighted issues such as the improper construction of the jury’s verdict form, which violated Apple’s right to a unanimous jury under the Seventh … Read more

AbbVie Secures $56M in Royalty Victory Over Revance in Botox Patent Dispute

by

CHICAGO – AbbVie has secured a significant legal victory in its ongoing battle over Botox-related patents. A jury has awarded the pharmaceutical company $56 million in royalties from Revance Therapeutics, affirming AbbVie’s claims of patent infringement. The case revolved around a contested patent for the use of a specific botulinum toxin formulation, which AbbVie argued Revance had violated with its own injectable therapy. This ruling underscores AbbVie’s commitment to protecting its intellectual property, particularly given the competitive landscape in the cosmetic and therapeutic market for neuromodulators. AbbVie has been a dominant player in the botulinum … Read more

Austin Jury Hands Down $9.2 Million Verdict to Katana in Landmark Patent Dispute

by

AUSTIN, Texas — A jury has awarded Katana, a Texas-based technology company, $9.2 million in a patent infringement case, marking a significant victory for the firm. The case revolved around allegations that a competitor unlawfully used its patented technology, a claim that sparked a legal battle in the federal court. The trial, which drew considerable attention, required jurors to examine the details of Katana’s patented innovations. The jury’s decision underscores the importance of intellectual property rights in the fast-evolving tech industry, where companies invest heavily in research and development. Katana’s victory represents not just a … Read more